These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
390 related items for PubMed ID: 31657659
1. Synergistic Activities of Colistin Combinations with Meropenem, Sulbactam, Minocycline, Disodium Fosfomycin, or Vancomycin Against Different Clones of Carbapenem-Resistant Acinetobacter baumannii Strains. Sertcelik A, Baran I, Akinci E, Mumcuoglu I, Bodur H. Microb Drug Resist; 2020 May; 26(5):429-433. PubMed ID: 31657659 [Abstract] [Full Text] [Related]
6. In vitro activity of apramycin (EBL-1003) in combination with colistin, meropenem, minocycline or sulbactam against XDR/PDR Acinetobacter baumannii isolates from Greece. Galani I, Souli M, Katsala D, Karaiskos I, Giamarellou H, Antoniadou A. J Antimicrob Chemother; 2024 May 02; 79(5):1101-1108. PubMed ID: 38501368 [Abstract] [Full Text] [Related]
13. In vitro effects of sulbactam combinations with different antibiotic groups against clinical Acinetobacter baumannii isolates. Deveci A, Coban AY, Acicbe O, Tanyel E, Yaman G, Durupinar B. J Chemother; 2012 Oct 02; 24(5):247-52. PubMed ID: 23182043 [Abstract] [Full Text] [Related]
14. Dose Optimization of Colistin Combinations against Carbapenem-Resistant Acinetobacter baumannii from Patients with Hospital-Acquired Pneumonia in China by Using an In Vitro Pharmacokinetic/Pharmacodynamic Model. Bian X, Liu X, Chen Y, Chen D, Li J, Zhang J. Antimicrob Agents Chemother; 2019 Apr 02; 63(4):. PubMed ID: 30745385 [Abstract] [Full Text] [Related]
15. In vivo efficacy of combination of colistin with fosfomycin or minocycline in a mouse model of multidrug-resistant Acinetobacter baumannii pneumonia. Ku NS, Lee SH, Lim YS, Choi H, Ahn JY, Jeong SJ, Shin SJ, Choi JY, Choi YH, Yeom JS, Yong D, Song YG, Kim JM. Sci Rep; 2019 Nov 20; 9(1):17127. PubMed ID: 31748527 [Abstract] [Full Text] [Related]
16. In vitro Evaluation of the Colistin-Carbapenem Combination in Clinical Isolates of A. baumannii Using the Checkerboard, Etest, and Time-Kill Curve Techniques. Soudeiha MAH, Dahdouh EA, Azar E, Sarkis DK, Daoud Z. Front Cell Infect Microbiol; 2017 Nov 20; 7():209. PubMed ID: 28596943 [Abstract] [Full Text] [Related]
17. In vitro activities of carbapenem/sulbactam combination, colistin, colistin/rifampicin combination and tigecycline against carbapenem-resistant Acinetobacter baumannii. Song JY, Kee SY, Hwang IS, Seo YB, Jeong HW, Kim WJ, Cheong HJ. J Antimicrob Chemother; 2007 Aug 20; 60(2):317-22. PubMed ID: 17540672 [Abstract] [Full Text] [Related]
18. In Vitro Synergistic Activity of Antimicrobial Agents in Combination against Clinical Isolates of Colistin-Resistant Acinetobacter baumannii. Bae S, Kim MC, Park SJ, Kim HS, Sung H, Kim MN, Kim SH, Lee SO, Choi SH, Woo JH, Kim YS, Chong YP. Antimicrob Agents Chemother; 2016 Nov 20; 60(11):6774-6779. PubMed ID: 27600048 [Abstract] [Full Text] [Related]
19. A prospective evaluation of synergistic effect of sulbactam and tazobactam combination with meropenem or colistin against multidrug resistant Acinetobacter baumannii. Marie MA, Krishnappa LG, Alzahrani AJ, Mubaraki MA, Alyousef AA. Bosn J Basic Med Sci; 2015 Oct 14; 15(4):24-9. PubMed ID: 26614848 [Abstract] [Full Text] [Related]
20. Activities of colistin- and minocycline-based combinations against extensive drug resistant Acinetobacter baumannii isolates from intensive care unit patients. Liang W, Liu XF, Huang J, Zhu DM, Li J, Zhang J. BMC Infect Dis; 2011 Apr 27; 11():109. PubMed ID: 21521536 [Abstract] [Full Text] [Related] Page: [Next] [New Search]